We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Describing the Impact of Maternal Hyperimmune Globulin and Valacyclovir on the Outcomes of Cytomegalovirus Infection in Pregnancy: A Systematic Review.
- Authors
Fitzpatrick, Alyssa; Cooper, Celia; Vasilunas, Nan; Ritchie, Brett
- Abstract
Cytomegalovirus (CMV) is the leading infectious cause of congenital neurological disabilities. Valacyclovir and CMV hyperimmune globulin (HIG) may reduce vertical transmission and sequelae in neonates. A systematic review on valacyclovir and CMV HIG in preventing vertical transmission or reducing sequelae in neonates was conducted to 3 September 2021. Valacyclovir as a preventive strategy was supported by a well-conducted randomized controlled trial. Evidence supporting valacyclovir as a treatment strategy was limited to observational studies at moderate risk of bias. CMV HIG was not supported as a preventive strategy in 2 randomized controlled trials, which contrasted with observational studies. Evidence favoring CMV HIG as a treatment strategy was limited to observational studies at moderate risk of bias. The role of valacyclovir and CMV HIG in CMV infection in pregnancy is still being defined. Valacyclovir to prevent vertical transmission has the highest quality evidence in favor of use.
- Subjects
THERAPEUTIC use of immunoglobulins; ONLINE information services; VALACYCLOVIR; MEDICAL information storage &; retrieval systems; CONFIDENCE intervals; CYTOMEGALOVIRUS diseases; SYSTEMATIC reviews; PREGNANCY outcomes; QUALITY assurance; DESCRIPTIVE statistics; MEDLINE; ODDS ratio; LOGISTIC regression analysis; VERTICAL transmission (Communicable diseases); PREGNANCY
- Publication
Clinical Infectious Diseases, 2022, Vol 75, Issue 8, p1467
- ISSN
1058-4838
- Publication type
Article
- DOI
10.1093/cid/ciac297